PLZF Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of PLZF monoclonal antibodies for investigating the promyelocytic leukemia zinc finger (PLZF) protein. PLZF monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PLZF is a transcription factor that plays a critical role in regulating gene expression during immune cell development and differentiation. The protein is particularly important in the function of natural killer T (NKT) cells and influences various biological processes, including tumor suppression and immune response. Understanding PLZF functionality is essential for elucidating its involvement in diseases such as cancer and autoimmune disorders. Researchers can explore PLZF expression patterns across different cell types and tissues using specific detection methods. Advanced research techniques enable scientists to examine PLZF localization and interactions with other cellular components. Investigating PLZF regulation mechanisms provides insights into potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing our understanding of PLZF's role in health and disease.